Molecular and Cellular Biology 1994-02-01

Cloning and characterization of KNR4, a yeast gene involved in (1,3)-beta-glucan synthesis.

Z Hong, P Mann, N H Brown, L E Tran, K J Shaw, R S Hare, B DiDomenico

Index: Mol. Cell. Biol. 14(2) , 1017-25, (1994)

Full Text: HTML

Abstract

k9 killer toxin from Hansenula mrakii was used to select a number of resistant mutants from Saccharomyces cerevisiae. Preliminary biochemical and genetic studies showed that some of them acquired structural defects in the cell wall. One of these mutants, the knr4-1 mutant, displays a number of cell wall defects, including osmotic sensitivity; sensitivity to cercosporamide, a known antifungal agent; and resistance to Zymolyase, a (1,3)-beta-glucanase. We report here the isolation and analysis of the KNR4 gene. DNA sequence analysis revealed an uninterrupted open reading frame which contains five potential start codons. The longest coding template encodes a protein of 505 amino acids with a calculated molecular mass of 57,044 Da. A data base search revealed 100% identity with a nuclear protein, SMI1p. Disruption of the KNR4 locus does not result in cell death; however, it leads to reduced levels of both (1,3)-beta-glucan synthase activity and (1,3)-beta-glucan content in the cell wall. The gene was mapped to the right arm of chromosome VII.


Related Compounds

  • Cercosporamide

Related Articles:

Bioactive metabolites from Phoma species, an endophytic fungus from the Chinese medicinal plant Arisaema erubescens.

2012-02-01

[Appl. Microbiol. Biotechnol. 93(3) , 1231-9, (2012)]

Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursors.

2013-05-02

[Blood 121(18) , 3675-81, (2013)]

Fermentative production of self-toxic fungal secondary metabolites.

2010-04-01

[J. Ind. Microbiol. Biotechnol. 37(4) , 335-40, (2010)]

Synthesis and biological evaluation of novel (-)-Cercosporamide derivatives as potent selective PPARγ modulators.

2012-08-01

[Eur. J. Med. Chem. 54 , 522-33, (2012)]

Discovery of a novel selective PPARgamma modulator from (-)-Cercosporamide derivatives.

2010-04-01

[Bioorg. Med. Chem. Lett. 20(7) , 2095-8, (2010)]

More Articles...